ArticleCancers2022

Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.

Juan L Callejas-Valera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.